
1. J Am Soc Nephrol. 2021 Nov;32(11):2725-2727. doi: 10.1681/ASN.2021050672.

Impaired Humoral but Substantial Cellular Immune Response to Variants of Concern 
B1.1.7 and B.1.351 in Hemodialysis Patients after Vaccination with BNT162b2.

Thieme CJ(1), Blazquez-Navarro A(1)(2), Safi L(2), Kaliszczyk S(2), Paniskaki
K(3), Neumann IE(1), Schmidt K(1), Stockhausen M(2), Hörstrup J(4), Cinkilic
O(5), Flitsch-Kiefner L(6), Meister TL(7), Marheinecke C(7), Pfaender S(7),
Steinmann E(7), Seibert FS(2), Stervbo U(2), Westhoff TH(2), Roch T(1)(2), Babel 
N(8)(2).

Author information: 
(1)Berlin Center for Advanced Therapies, Charité-Universitätsmedizin Berlin,
Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin,
Berlin, Germany.
(2)Center for Translational Medicine and Immune Diagnostics Laboratory, Medical
Department I, Marien Hospital Herne, University Hospital of the Ruhr-University
Bochum, Herne, Germany.
(3)Department of Infectious Diseases, West German Centre of Infectious Diseases, 
University Hospital Essen, University Duisburg-Essen, Essen, Germany.
(4)Kuratorium für Dialyse und Nierentransplantat, Berlin, Germany.
(5)Dialyse Schwerte, Schwerte, Germany.
(6)Kuratorium für Dialyse und Nierentransplantat, Hagen, Germany.
(7)Department of Molecular and Medical Virology, Ruhr University, Bochum,
Germany.
(8)Berlin Center for Advanced Therapies, Charité-Universitätsmedizin Berlin,
Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin,
Berlin, Germany nina.babel@elisabethgruppe.de.

DOI: 10.1681/ASN.2021050672 
PMID: 34716240  [Indexed for MEDLINE]

